EPCAM and cancer: The article explores alternative biomarkers and innovative strategies for CTC capture, evaluates EpCAM-based and independent enrichment techniques, and emphasizes the need for multifaceted approaches that combine analysis of molecular and biophysical characteristics to improve liquid biopsy sensitivity and specificity for cancer diagnostics, prognostics, and therapeutic monitoring.